In this work, silver nanoparticles (AgNPs) were synthesized by a green methodology using maltose and cysteine. Fungistatic and fungicide activity were evaluated on Candida albicans ATCC 10231 and Candida parapsilosis ATCC 22019. AgNPs were characterized by UV-visible spectrophotometry, scanning electron microscopy (SEM), transmission electron microscopy (TEM) and dynamic light scattering in dynamic mode (DLS). AgNPs were spherical shape with sizes between 10-20 nm and positive surface charge. Inhibitory effect was determining by both minimum inhibitory concentration that inhibit 50% of fungal growth (MIC 50 ) and minimum fungicide concentration (MFC) of AgNPs. MIC 50 values obtained were between 0.02 to 0.25 g/ml AgNPs and MFC values between 0.25 to 0.5 g/ml for the two strains of Candida. TEM images showed that AgNPs caused drastic alteration on cell wall (increased thickness) and disruption of cytoplasmic membrane. Finally, cytotoxic effect of AgNPs on murine fibroblast was evaluated and a cytotoxic effect on 50% of murine fibroblast cells (CC 50 ) were obtaining at a mean concentration of 10 g/ml of AgNPs (up to 500 times higher than MIC 50 ). In conclusion, we can consider AgNPs as an alternative in the development of new antifungal agents with fungicide effect on Candida species at non-toxic concentrations for mammalian cells.
INTRODUCTION
Currently, Candida is considered by the National Nosocomial Infections Surveillance System (NNISS, USA) the fourth blood pathogen at nosocomial level, with a high mortality rate (it has been estimated that this can reach up to 45%), and causing of 60 to 80% of cutaneous candidiasis. [1] [2] [3] Among isolated species with high frequency of human mycosis are highlighted Candida albicans, Candida tropicalis, Candida parapsilosis, Candida krusei and Candida glabrata. Among them, C. albicans is the most relevant in terms of pathogenicity. 4 5 * Author to whom correspondence should be addressed.
At world level, epidemiology of infectious diseases caused by fungi is changing. 6 7 Although C. albicans is the most common fungal pathogen, different Health Entities in Europe, Asia and South America have described quick emergencies caused by C. parapsilosis. In fact, this considered as the second specie of Candida with greater frequency of isolations in hemocultures. 8 9 Mycosis caused by C. parapsilosis and C. albicans are associated to use of permanent catheters, inducing production of biofilms onto prosthetic materials, which favors colonization and invasion of epithelial tissue in the cell host. 10 11 Incidence of Candidiasis has been glaringly increased in the last years, disposal of antimycotic compounds is limited to quinolones, some azoles, polyenes and equinocandines; Most of them have one or more limitations, as adverse effects, reduced antimycotic spectrum and poor penetration into some cell tissues. Likewise, treatment of candidiasis is more difficult due to resistance to conventional antifungals and minimal fungicide activity of azoles. 13 14 Three possible mechanisms of antifungal resistance have been described for Candida species: (1) Modification of target enzyme, (2) Inability to reach adequate concentration of antifungal in the action site by presence of permeability barriers or active/flux pump efflux systems of the antibiotic, and (3) inactivation of antimycotic compounds by enzymatic or chemical modification. [12] [13] [14] It has been described that resistance given by increasing in efflux of antifungal agents is due to over-expression of efflux genes, CDR1, CDR2 (family ABC of membrane carrier proteins) and MDR1 (major family of facilitated protein transport). 14 15 In this sense, ability of Candida spp. to exhibit low sensitivity and chemotherapeutic resistance to conventional antifungals has open fields for development of new compounds with high antifungal activity and minimal cytotoxic effects. 15 16 On potential alternative is use of metallic nanomaterials as silver nanoparticles (AgNPs). 15 17 18 Because of nanometric size of AgNPs, an efficient interaction with the microorganisms is facilitated. In addition, most of studies have been focused on antibacterial activity of AgNPs; [19] [20] [21] however, this type of nanomaterials can be used as good choice in the control of fungal infections. 16 22 23 One of the most remarkable applications of nanomaterials in the field of biological sciences is the development of new antimicrobial compounds, also the nanoparticles are specially used as tools in the administration of medicines, gene delivery systems and anticancer drugs. [17] [18] [19] [20] Among nanomaterials with high antimicrobial activity, AgNPs are the most used. 15 16 AgNPs present unusual physic-chemical properties, such as high electric and thermal conductivity, improvement in surface dispersion Raman signal and high catalytical activity. Additionally, an important biocide effect against bacteria, fungi and viruses has been proved, which it is caused due to large surface area per volume, allowing a big interaction with the microbial cells. [16] [17] [18] [19] [20] [21] [22] [23] [24] AgNPs can be synthesized through different methodologies, providing particular morphologies and physicochemical properties. 21 For this aim, chemical reduction is the most often methodology used. This requires three basic components: metallic precursors, reducing agents and a stabilizer. 20 In synthesis of AgNPs mediated by chemical reduction, it is ideal that reducing agents are compounds with low or minimal cytotoxicity. 23 In the present study, AgNPs were synthesized using green synthesis mediated by maltose or cysteine as reducing agents. In addition, AgNPs were obtained with acceptable mean sizes (10-20 nm) and without further purification requirements. At the same time, this work was aimed to prove antifungal activity of these nanomaterials against two species of Candida, and its effect on cell structure of fungi,
MATERIAL AND METHODS

Reagents and Fungal Strains
All reagents used in this study were of analytical grade and used without further additional purification. Silver nitrate (AgNO 3 , 99.98%), L-cysteine (C 3 H 7 NO 2 S, >99%), maltose (99.5%) and the culture medium Sabouraud 2% Dextrose Agar (SDA) were purchased from Merck (Darmstadt, Germany). Cetyl tri-methyl-ammonium bromide (CTAB, 99%), culture medium Roswell Park Memorial Institute (RPMI 1640), Type A porcine gelatin (∼50.000-100.000), fluconazole (C 13 25 with some modifications in order to obtain both smaller and homogeneous AgNPs. A solution of AgNO 3 (0.01 M), 800 l of cysteine (0.01 M) and 1.2 ml of CTAB (0.01 M) was mixed and gently shaken. Subsequently, deionized water was added in order to obtain a final volume of 20 ml. PVA was added at a final concentration of 0.02% (w/v). Finally, this mixture was subjected to sonication at 37 KHz during 2 h. 21 Evidence of a redorange suspension indicated formation of AgNPs.
Synthesis of AgNPs Through Chemical
Reduction with Maltose (AgNPs-Mal) Synthesis of AgNPs using a green route was performed according to Oluwatobi et al. 26 with some modifications in order to obtain both smaller and homogeneous AgNPs. Initially, gelatin was dissolved in distilled water under stirring until formation of a translucent solution at 40 C. Subsequently, AgNO 3 (1 M) was gently added a controlled agitation. Then, a solution of maltose (2 M) was added to this resultant solution and maintained at 75 C during 24 h in absence of light. 27 Candida spp. cultures in SDA at 35 C for 48 h were performed. Yeast inoculum was adjusted in order to obtain a final concentration of 0.5-2 5 × 10 3 Colony Forming Units (CFU)/ml using 0.85% (w/v) sterile saline solution and Roswell Park Memorial Institute (RPMI 1640) medium supplemented with L-glutamine, without sodium bicarbonate and 0.2% (w/v) glucose (pH 7 0 ± 0 1).
AgNPs Characterization
In this study, concentrations of AgNPs ranging 0.01-10 g/ml were evaluated. For this, a stock solution of 200 g/ml was used. The experiments were carried out in 96-well microplates using ratios inoculum: solution AgNPs of 1:1. Microplates were incubated at 35 C. Likewise, we performed sensitivity control of fungal strains to fluconazole, using a range of antibiotic concentrations of 0.5-64 g/ml. Subsequently, visual readings of fungal cultures were carried out at 24 and 48 h. Three independent experiments with corresponding culture medium sterility and fungal growth (without fluconazole or AgNPs) controls were also performed.
Minimum Fungicide Concentration (MFC)
From cell cultures where was obtained a MIC 50 , 100 l of broth culture were withdrawn and added to 900 l RPMI 1640 in order to grow living remnant fungal cells. 28 These cell cultures were incubated at a 35 C during 24 h. Subsequently, an aliquot of every cell culture was withdrawn and used for inoculation of SDA agar plates in order to check no fungal growth. These agar plates were incubated during 48 h at 35 C. Finally, we determined MFC, which was defined as the lowest concentration of AgNPs that causes a reduction in CFU >99.9% compared to cells cultured without AgNPs.
Antifungal Effect of AgNPs by Electron
Microscopy Effect of AgNPs on Candida spp. was determined by SEM and TEM, allowing observation of yeast-AgNPs interactions. SEM: C. parapsilosis ATCC 22019 as yeast model were treated with MIC 50 values of silver nanoparticles (AgNPs-Cys or AgNPs-Mal) in RPMI 1640 medium buffered with 0.16 M 3-(N-Morpholino) propanesulfonic acid (MOPS) for 48 h, at 35 C, collected by centrifugation and washed three times in PBS buffer. Subsequently, yeast were fixed overnight at 4 C with 2.5% glutaraldehyde and 4% paraformaldehyde in 0.1 M cacodylate buffer, pH 7.2. After fixation, small drops of the sample were placed on a specimen support with poly-L-lysine. Postfixation was carried out with 1% osmium tetroxide in cacodylate buffer containing 0.8% potassium ferrocyanide and 5 mM CaCl 2 for 30 minutes. After, the samples were dehydrated in graded ethanol, critical-point dried in CO 2 , coated with gold in a sputter system in a high-vacuum chamber and observed in a scanning electron microscope (FEI Quanta 250 model, FEI, Netherlands). TEM: C. albicans ATCC 10231 and C. parapsilosis ATCC 22019 were treated with MIC 50 of silver nanoparticles (AgNPs-Cys or AgNPs-Mal) in RPMI 1640 medium buffered with 0.16 M MOPS for 48 h, at 35 C, collected by centrifugation and washed three times in PBS buffer. After that, yeasts were fixed overnight at 4 C with 2.5% glutaraldehyde and 4% paraformaldehyde in 0.1 M cacodylate buffer, pH 7.2. Postfixation was carried out in 1% osmium tetroxide in cacodylate buffer containing 1.25% potassium ferrocyanide and 5 mM CaCl 2 for 1 h. Next, the yeasts were dehydrated in increasing ethanol concentration and embedded in spurr's resin. Ultrathin sections were stained with uranyl acetate and lead citrate, and observed in a transmission electron microscope (Spirit model, FEI, Netherlands).
Cytotoxicity Assay
Murine NIH/3T3 fibroblast cells (ATCC CRL-1658) were maintained in RPMI 1640 culture medium supplemented with 5% Inactive Fetal Bovine Serum (IFBS, Hyclone) at 37 C, 5% CO 2 and 95% moisture. Cytotoxicity of AgNPs on Murine fibroblasts was determined by MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. 29 30 Mammalian cells (10 5 cells/ml) were cultured in 96-well plates with increasing concentrations (1.1, 3.3, 10, and 30 g/ml) of AgNPs. Then, cells were incubated with MTT (5 g/ml) for 4 h at 37 C. The supernatant was removed and 100 l of dimethyl Table I shown a summary of physicochemical properties of AgNPs synthesized by means chemical reduction by cysteine and maltose. Figure 3 shows the XRD pattern of silver nanoparticles using cysteine as reducer agent. These patterns were compared and interpreted with standard data of International Centre of Diffraction Data (ICDD). The peaks characteristics for silver were consistent with a face-centered cubic system (FCC). XRD spectrum confirmed crystalline structure of silver nanoparticles according to data available literature (JCPDS, No. 4-0783).
MIC 50 and MFC
One of the experiments of broth microdilution in order to determine minimum inhibitory concentration (MIC 50 ) of AgNPs-Cys of both Candida species is presented as mode of example (Fig. 4) for C. parapsilosis and C. albicans, respectively (Table II) . Likewise, antifungal effect of fluconazole on C. albicans showed a MIC 50 of 16 g/ml, presenting sensitivity dose-dependent pattern (SDD: MIC 50 16-32 g/ml) and C. parapsilosis showed sensitivity to 2 g/ml (S: MIC 50 <8 g/ml) for this type of azolic antifungal. Moreover, MFC of AgNPs-Cys and AgNPs-Mal were 0.25 g/ml for C. parapsilosis and 0.5 g/ml for C. albicans (Table II) . Fungal cultures were exposed to concentrations of CTAB, PVA and gelatin used for the synthesis of AgNPs. It was determined that these stabilizing agents have not inhibitory effects on Candida cells (data not shown).
Antifungal Effect of AgNPs by Electron Microscopy
The topography of yeasts from C. parapsilosis untreated with AgNPs showed a uniform surface (Figs. 5(a, b) ), but when treated with MIC 50 of AgNPs-Cys or AgNPs-mal we observed the nanoparticles deposited on the surface (arrow in Fig. 5(d) ) and the cell wall slight damage (arrow in Fig. 5(f) ), respectively. Ultra-thin sections of untreated yeasts of C. albicans ATCC 10231 and C. parapsilosis ATCC 22019 showed a normal cell ultrastructure with compact cell wall (cw), continuous cytoplasm membrane (cm), and electron-dense cytoplasm (Figs. 6(a and b), respectively). However, yeasts of C. albicans and C. parapsilosis treated with MIC 50 of silver nanoparticles (AgNPs-Cys or AgNPs-Mal) presented increase in cell wall thickness, disruption or discontinuous cytoplasm membrane, and loss of the cytoplasmic material (Figs. 6(c and f) ).
Cytotoxicity of AgNPs on NIH/3T3 Fibroblasts
In Table III is presented results on cytotoxicity effect of AgNPs on fibroblast cell line NIH/3T3. Results from two independent experiments are shown. These results show that AgNPs mean concentration around 10 g/ml and above 30 g/ml for cytotoxicity of 50% and 90% (CC 50 , CC 90 on fibroblast cells, respectively.
DISCUSSION
Nowadays the research has been directed towards finding compounds for combating infectious diseases primarily of bacterial origin. 20 21 However, it also requires the development of new antifungal agents due to different diseases caused by fungi and the development of resistance to conventional antifungals. 18 31-36 Our study proves that AgNPs, synthesized by chemical reduction using cysteine or maltose, could be a promising alternative of antifungal compounds, showing both potent and efficient antifungal activity against Candida species. UV-Vis spectra confirmed efficient synthesis of AgNPs by chemical reduction with cysteine and maltose. Absorbance corresponding to SPR of AgNPs was detected in the visible spectrum with a characteristic peak around 410 nm for both types of synthesized nanoparticles. 25 36 In addition, blue-shift in the UV-visible spectrum was observed, which it is indicating a decrease in mean nanoparticle size. This was confirmed by DLS determinations for both types of nanoparticles synthesized. AgNPs showed positive net charges. Although Petica et al. 37 have proposed that nanoparticles with surface in the range −20 mV to 20 mV display low stability for its tendency to agglomeration, AgNPs-Cys, with charges around +4 05 ± 1 3 mV (Table I) , were stable due to action of surfactants CTAB and PVA, those avoid nanoparticle agglomeration though formation of micelles. (Figs. (a-b) ) and Candida cells treated with MIC 50 of AgNPs-Cys (Figs. (c-d) ) and AgNPs-Mal (Figs. (e-f) ) is observed. The surface of the control cells (a-b) is continuous and uniform. In contrast, the treated cells have adhered AgNPs (Figs. (c-d) ) and with slight alteration in the cell surface (Figs. (e-f) ).
Hydrodynamic size for nanoparticles observed by DLS was comparable to mean sizes obtained by TEM analyses. Electronic microscopic images showed spherical shapes for most nanoparticles, which is indicating that these nanoparticles could be effective as antimicrobial compounds, such as it has been described by many authors in literature. 15 38 On the other hand, the XRD pattern was according to the crystalline pattern of AgNPs. However, evidence of different peaks in the sample indicated presence of impurities, probably AgBr, in its facet bromargyrite with hexoctahedral crystalline system. This impurity could be produced by electrostatic interactions between bromide ion (Br-) from CTAB and non-reduced Ag+ in solution. 25 TEM images of AgNPs-Cys show some non-linear agglomerated chains of nanoparticles, a likely indicator of interaction among these nanomaterials. These agglomerations did not affect the stability of colloidal suspension and favored the antifungal activity, because a higher interaction of nanoparticles with the microorganism is produced. 25 (Figs. (a-b) ). On the other hand, yeasts treated with AgNPs presented cytoplasm less dense when compared with untreated yeast (Figs. (c-f) ). Moreover, Figures (c-f) showed yeasts with drastic alteration on cell wall (increased thickness) and disruption or discontinuous cytoplasm membrane. Bars = 0 2 m.
observed in TEM images has been attributed to possible formation of an insoluble Cysteine-Ag complex in the reaction medium when is added cysteine to the reaction medium formed by metallic silver and CTAB. 25 40 50 values for nanoparticles were found in the range 0.02 to 0.25 g/ml for the fungal strains. In general, AgNPs-Cys and AgNPs-Mal exhibited in vitro a higher pharmacological potency than fluconazole, because lower concentrations of AgNPs caused the same inhibitory effect at 50% of the fungal cells. For example, fluconazole inhibited 50% of C. albicans cells at 16 g/ml while with 0.25 g/ml AgNPs an inhibitory antifungal activity (MIC 50 ) was produced. In this sense, we obtained the same antifungal effect using AgNPS a concentration 64 times lower than fluconazole.
At the same time, it is possible to consider that AgNPs displayed larger pharmacological efficacy in vitro than fluconazole. Antifungal effect of AgNPs was larger than fluconazole, because AgNPs caused cell death (fungicide effect) in ranges of concentrations between 0.25 and 0.5 g/ml on Candida spp., while fluconazole only was effective as fungistatic (inhibition of cell growth) at 64 g/ml. In vitro antifungal effect of AgNPs determined as MFC values was comparable and even better than other antifungal of wide spectrum such as amphotericin B (MFC ranging 2-16 g/ml), azoles as posaconazole (MFC around 8 g/ml), itraconazole and voriconazole (MFC >10 g/ml), and echinocandin as caspofungin with fungicide activity around 1 g/ml. 41 Antimicrobial activity exhibited by AgNPs on Candida spp. is caused probably by simultaneous action of nanoparticles on multiple targets, giving a fungicide effect on the fungal cells. 22 23 42 On the other hand, fluconazole is only active in one target, inhibiting the fungal cytochrome P450 enzyme 14-alpha-demethylase, interfering with synthesis of the fungal cell membrane, which affects integrity of cell membrane due to reduction on ergosterol concentration. 43 44 It is important to remark that biocide effect of silver nanoparticles is attributed to its nanometric size and large surface area, which facilitates its interaction with the microbial cells. At the same time, electrostatic interaction cell-nanoparticle is improved by positive surface of nanoparticles, which it is playing a significant role in the antimicrobial mechanism of AgNPs. 44 45 It has been described that both cell walls and electron transference can be affected by nanoparticle action, which finally causes cell lysis. 46 Entry of nanoparticles to cells causes oxidation of cell components through production of reactive oxygen species (ROS). 47 Gogoi et al. 48 have postulated that nanoparticles can directly react with DNA, proteins, and in consequence, affect respiratory chain and cell division. In this sense, silver ions can penetrate cell wall and form complex with nitrogenous bases of DNA, and therefore, condensate and reduce the replication process. 46 Additionally, silver ions can inhibit enzyme and protein expression, affecting ATP production. Ag+ reaction with thiol, phosphate, amine, imidazole and indole groups can cause enzyme inactivation and further cell death. 46 49 Kumar et al. 50 propose that silver ions react with sulfhydryl groups forming R-S-S-R, and blocking cell respiration.
It is evident the anchorage of AgNPs and further alteration of the cell surface of Candida (Fig. 5) . In addition, SEM images of cells treated with AgNPs showed some aggregates stuck on the cell surface, indicating an interaction of AgNPs among themselves. For this reason, this is suggesting that synthesized AgNPs with cysteine are producing a cluster of nanoparticles that acts in a simultaneous mode on the cell surface. 31 39 Moreover, TEM images (Fig. 6 ) confirm alterations at the cell Surface level. Cell walls (CW) of Candida yeasts treated with AgNPs were less compact, and displayed alterations in its shape and thickness and cytoplasmic discontinuity, which is indicating structural disorganization of the CW components. These damages on CW were comparable with those caused in sterilized cells. 51 In contrast, untreated yeasts possess an electro-dense cytoplasm with continuous cytoplasmic membrane and compact cell wall. Alterations in membrane and cell walls of Candida spp. treated with AgNPs, allows that nanoparticles can penetrate into the cells, facilitating interaction with enzymes and triggering inhibition of replication and cellular multiplication. Also, cell wall damages of fungi has dramatic effects in both growth and morphology of cells, because cell wall plays an important role in maintaining cellular rigidity, supporting of osmotic pressure and limiting of entry of toxic molecules. 31 52 53 Determination of toxicity of nanocompounds was a very important issue due to prevention of its use of nanoparticles in biomedical applications and effect of nanoparticles on mammalian cells. 38 43 It is known that AgNPs present multiple targets, simultaneous action on microbial cells (previously described) and these mechanisms of nanoparticles could be also produced on mammalian cells. 30 54 Nanoparticles can interact with enzymes as superoxide dismutase (SOD) and thioredoxin peroxidase until exhaust antioxidant defense mechanism of mammalian cells, which carries to accumulation of reactive oxygen species (ROS). 38 47 This accumulation can initiate an inflammatory response and produce alteration and destruction of mitochondria. In consequence, apoptogenic factors are released, and they activate cell death. 45 55 For this reason, we performed cytotoxicity analyses for both type of AgNPs, using MTT assay, which permits determination of metabolic activity at mitochondrial level. For these tests, we used fibroblasts cell in order to explore use of these nanoparticles as antifungal compound in some formulations, especially for treating cutaneous infections, that can afterwards be disseminate at systemic level.
In this study, AgNPs show cytotoxic effect in the 50% of murine fibroblast cells (CC 50 ) in a range of concentration of 7.72-11.21 g/ml. This CC 50 
